个人简介
教育经历
2010.10－2012.09 哈佛大学医学院 联合培养博士生
2009.09－2013.06 中山大学 肿瘤学 博士
2006.09－2009.06 中山大学 肿瘤学 硕士
2001.09－2006.06 广州医学院 临床医学 本科
工作经历
2024.01-至今 中山大学肿瘤防治中心 胃外科 主任医师
2018.01-2023.12 中山大学肿瘤防治中心 胃外科 副主任医师
2016.01-2017.12 中山大学肿瘤防治中心 胃外科 主治医师
2013.08-2015.12 中山大学肿瘤防治中心 胃胰科 医师
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Haibo Qiu, Sumei Cao , Ruihua Xu , Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2021, Cancer Communications. 2021 Oct;41(10):1037-1048.
Xiayao Diao, Yudong Ling, Yi Zeng, Yueqian Wu, Chao Guo, Yukai Jin, Xiaojiang Chen, Shoucheng Feng, Jianrong Guo, Chao Ding, Feiyu Diao, Zhicheng Du, Shanqing Li, Haibo Qiu*. Physical activity and cancer risk: a dose-response analysis for the Global Burden of Disease Study 2019. Cancer Communications. 2023 Nov;43(11):1229-1243.
Haibo Qiu, Xu Zhang, Jiali Qi, Jiangwen Zhang, Yin Tong, Lei Li , Li Fu, Yan-Ru Qin, Xinyuan Guan, Liyi Zhang. Identification and characterization of FGFR2+hematopoietic stem cell-derived fibrocytes as precursors of cancer-associated fibroblasts induced by esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2022 Aug 8;41(1):240.
Chen W#, Kuang Y#, Qiu HB#, Cao Z, Tu Y, Sheng Q, Eilers G, He Q, Li HL, Zhu M, Wang Y, Zhang R, Wu Y1, Meng F, Fletcher JA, Ou WB. Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Res. 2017 Sep 15;77(18):5107-5117.
Li J#, Zhang J#, Zhang Y#, Qiu HB#, Zhou Y, Zhou Y, Zhang X, Zhou Y, Zhu Y, Li Y, Wang M, Shen K, Tao K, Wu X, Wang H, Zhang B, Ling J, Ye Y, Wu X, Qu H, Ma Y, Jiao X, Zheng H, Jin J, Liu Z, Tan M, Fang Y, Zhang P, Zhang N, Lei C, Cai Z, Liang B, Peng Z, Huang Z, Dong J, Shen L. Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China. Eur J Cancer. 2024 Jan:196:113439.
Haibo Qiu. Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France. Cancer Communications.2019 Aug 8;39(1):45.
Haibo Qiu. Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer. Cancer Communications. 2020;40:194–196.
京公网安备 11010802027423号